IMS to follow drug wholesaler's decision over information supplies.

The Pharmaceutical Business Development Council (PBDC) earlier decided not to supply any drug sales informations to Zuellig. In this connection, IMS Health Korea, who is allegedly connected with Zuellig, replied to the PBDC's question to IMS on the subject of information data supplies to Zuellig that any informations as specified in the IMS contract would not be released to any third party with...